Synthesis and Anticonvulsive Activity of 3- and 4-Benzoylpyridine Oxime Derivatives


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Somente assinantes

Resumo

We present here the synthesis of 3- and 4-benzoylpyridine oxime derivatives with potential anticonvulsant action. The most active compound in the maximum electric shock test was 4-benzoylpyridine O-2-morpholinoethyloxime oxalate (1a), i.p. doses of 60 – 150 mg/kg of which increased the survival of mice to 100%. The best effect in the corasol antagonism test was obtained with 4-benzoylpyridine O-(isonicotinoyl)oxime (2c), i.p. doses of 12.5 mg/kg of which increased the survival of mice to 67% and the latent period of onset of generalized tonic-clonic convulsions to 52 sec. Compound 1a had low toxicity (the i.p. LD50 in mice was 316 mg/kg) and a therapeutic index of 21.

Sobre autores

L. Zhmurenko

V. V. Zakusov Science Research Institute of Pharmacology

Email: g.mokrov@gmail.com
Rússia, 8 Baltiicheskaya Street, Moscow, 125315

T. Voronina

V. V. Zakusov Science Research Institute of Pharmacology

Email: g.mokrov@gmail.com
Rússia, 8 Baltiicheskaya Street, Moscow, 125315

S. Litvinova

V. V. Zakusov Science Research Institute of Pharmacology

Email: g.mokrov@gmail.com
Rússia, 8 Baltiicheskaya Street, Moscow, 125315

L. Nerobkova

V. V. Zakusov Science Research Institute of Pharmacology

Email: g.mokrov@gmail.com
Rússia, 8 Baltiicheskaya Street, Moscow, 125315

I. Gaidukov

V. V. Zakusov Science Research Institute of Pharmacology

Email: g.mokrov@gmail.com
Rússia, 8 Baltiicheskaya Street, Moscow, 125315

G. Mokrov

V. V. Zakusov Science Research Institute of Pharmacology

Autor responsável pela correspondência
Email: g.mokrov@gmail.com
Rússia, 8 Baltiicheskaya Street, Moscow, 125315

T. Gudasheva

V. V. Zakusov Science Research Institute of Pharmacology

Email: g.mokrov@gmail.com
Rússia, 8 Baltiicheskaya Street, Moscow, 125315

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML

Declaração de direitos autorais © Springer Science+Business Media, LLC, part of Springer Nature, 2018